Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UDoTest was a digital health and diagnostics company that developed a business-to-business at-home lab testing and disease screening software platform for insurers, employers, laboratories, health plans, and consumers. The company focused on personalizing self-collection testing workflows and closing gaps in preventive screening through home-based sample collection and reporting. Its offerings supported screening across a broad range of conditions, including COVID-19 and other preventive health use cases, and were designed to integrate with employer wellness and payer programs. UDoTest appears to have operated commercially before being acquired by Recuro Health in 2021. Following the acquisition, the standalone company no longer appears to operate independently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UDoTest.